Slater, Accutane, Hoffman-LaRoche, Inflammatory Bowel Disease (IBD) & Crohn’s Disease case documents what many accutane prescription drug users may be experiencing today – potential inflammatory bowel disease (IBD), Crohn’s Disease or other problem from the use of the acne drug accutane. The court ruled on the motion.
To find out more on the case, see Case No. 10-6956 – March 24, 2011.
A brief summary of the facts include:
- Beginning in the fall of 2002, plaintiff was prescribed and began using Accutane for acne treatment.
- Plaintiff filled his Accutane prescriptions at Walgreens pharmacy, which provided him with WKH-prepared patient education monographs (“monographs”) containing Accutane drug information and warnings.
- After using Accutane for the period of time prescribed by his physician, plaintiff “experienced several adverse health effects culminating in a diagnosis of colitis and ulcerative colitis.”
ACCUTANE
Accutane (isotretinoin) is a drug that was developed by Hoffmann-La Roche Inc. for treating severe cystic (nodular) acne. Accutane is also marketed under the names Roaccutane, Amnesteem, Claravis and Sotret. Accutane is known as a retinoid, and is a synthetic form of Vitamin A. Accutane was approved by the U.S. Food and Drug Administration (FDA) in 1982.
Accutane Health Concerns
According to many reviews and reports, Accutane treatment may have a number of long term and serious side effects, including:
- Birth defects
- Suicide
- Depression
- Inflammatory Bowel Disease (IBD)
- Crohn’s Disease
- Colitis (ulcerative), and many other Accutane side effects
For more on Accutane, please follow this link…
WE ARE HERE TO HELP YOU PROTECT YOUR LEGAL RIGHTS